AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 MAR 7 - (NewsRx.com & NewsRx.net) --
by Michelle Marble, staff medical writer -- CpG motifs may influence the success of vaccines, immunotherapies, and gene therapies, Genzyme Corp. researchers suggest.
"The mammalian immune system has evolved mechanisms to recognize and respond to 'danger' signals arising from pathogens," said R.K. Scheule and colleagues at Genzyme. "Among those danger signals are the unmethylated CpG dinucleotide motifs found in bacteria."
According to the researchers, cytokines released by macrophages and related cells in response to CpG motifs are then responsible for activating other immune cells. These other immune cells, such as natural killer (NK) cells and T cells, help mediate the development of adaptive immune responses, Scheule et al. wrote in the journal Advanced Drug Delivery Reviews.
Small oligodeoxynucleotides containing stimulatory CpG motifs may also have the ability to induce these pro-inflammatory Th1 responses. As such, when generated intentionally, they may have potential use as vaccine adjuvants and for cancer immunotherapy ("The role of CpG motifs in immunostimulation and gene therapy," ...